Advertisement
Advertisement
IKT
Inhibikase Therapeutics, Inc. Common Stock
1.50
USDSponsored
+0.06
+4.17%
Nov 06, 15:59 UTC -5
Closed
After-Market
1.50
0.00
-0.33%
Inhibikase Therapeutics, Inc. Common Stock (IKT)
Inhibikase Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 208.61M |
| Beta | 0.94 |
| Earnings Per Share (EPS) | -0.43 |
| Price-to-Book (P/B) Ratio | 1.29 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -42.80% |
| Current Ratio | 15.82% |
| Free Cash Flow | -24.50M |
